es may commence immediately following
IRB approval. </p>

<p><u>IRB Review of the Protocol and Informed Consent</u> </p>

<p>Once the final SR/NSR decision has been rendered by the IRB (or FDA), the IRB must
consider whether or not the study should be approved. In considering whether a study
should be approved, the IRB should use the same criteria it would use in considering
approval of any research involving an FDA regulated product [21 CFR 56.111]. Some NSR
studies may also qualify as &quot;minim